Search results for: Precision Medicine
Filter search results
OHE Lunchtime Seminars: Steven Pearson and Janel Hanmer
4 October 2018
…address several limitations of the existing generic preference measures including: (1) fully capturing the entire range of a construct, (2) measuring an individual’s health status with greater precision, and (3)…
Sources of Information for Prescribing Doctors in Britain
9 January 1977
…voluntary and statutory controls on their sales promotion. Both the industry’s Code of Practice and the Government’s regulations under the 1968 Medicines Act are being considerably tightened in order to…
The Value of Knowing and Knowing the Value: Improving the Health Technology Assessment of Complementary Diagnostics
5 July 2016
…analysis broadens the use of the term beyond predicting response to specific medicines. For the Joint OHE/EPEMED press rel ease The White Paper: The Value of Knowing and Knowing the…
Cost-effectiveness Analysis of Gene Therapies for Inherited Eye Disease: Are Current Discounting Approaches Too Short-sighted?
15 February 2023
…Published online June 2021. Accessed September 30, 2022. https://www.ace-hta.gov.sg/docs/default-source/process-methods/ace-drug-and-vaccine-evaluation-methods-and-process-guide-(june-2021).pdf Danish Medicines Council. The Danish Medicines Council Methods Guide For Assessing New Pharmaceuticals. Published online 2021. Accessed November 9, 2022. https://medicinraadet.dk/media/wq0dxny2/the_danish_medicines_council_methods_guide_for_assessing_new_pharmaceuticals_version_1-…
OHE Lunchtime Seminar: Health Technology Assessment Scientific and Outcomes Advice on Medicinal Drug Development
4 October 2016, 11:00pm
…(Medicines and Healthcare products Regulatory Agency, MHRA, and European Medicines Agency, EMA). Despite these efforts HTA SA is not routinely integrated into the clinical development of new medicines and it…
Around The World in HTAs: Greece – Late but with an Optimistic Future
18 October 2023
…users’ private spending making up the remaining 38% (Hellenic Statistical Authority (ELSTAT), 2023). The HTA process framework The value assessments of medicines and medical devices are managed separately. Assessment of medicines…
OHE at AES: Medicines Prices in the UK, Health Inequalities in Costa Rica
25 June 2013
…recent research on projecting medicines expenditures in the NHS using a bottom-up, rather than a top-down, approach. OHE’s participation at the 33rd Meeting of the Spanish Health Economics Association (AES)…
Defining Innovation in Medicines and Transforming it into Value
3 July 2013
…of key European countries to valuing innovation in medicines and explained how actions by payers can affect the rate and direction of innovation. Defining Innovation in Medicines: How to Transform…
The WHO Technical Report on the Pricing of Cancer Medicines: Missing a central role for HTA and value assessment
1 April 2019
The WHO Technical Report: Pricing of cancer medicines and its impacts (“the Report”) was published in order to address requests made in a resolution adopted by the 2018 Seventieth World…